News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Industry News Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels February 26, 2018
News Daily News FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market Yael L. Maxwell February 26, 2018
News Conference News EuroPCR 2017 Slimmest Stent to Date Looks Promising in Small Study Shelley Wood May 19, 2017
News Industry News Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 18, 2017
News Conference News TCT 2016 LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years Yael L. Maxwell October 30, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Conference News TCT 2015 Intracoronary Brachytherapy Reduces DES ISR but Restenosis not Eliminated October 12, 2015
News Conference News AHA 2012 ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients Jason Kahn November 04, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Daily News GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders L.A. McKeown March 15, 2011